These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37376990)

  • 1. Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease.
    Coban N; Erkan AF; Ozuynuk-Ertugrul AS; Ekici B
    Acta Cardiol; 2023 Oct; 78(8):945-956. PubMed ID: 37376990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study.
    Szydełko J; Czop M; Petniak A; Lenart-Lipińska M; Kocki J; Zapolski T; Matyjaszek-Matuszek B
    Cardiovasc Diabetol; 2024 Jul; 23(1):278. PubMed ID: 39080630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of miR-130b-5p in peripheral blood are associated with severity of coronary artery disease.
    Coban N; Ozuynuk AS; Erkan AF; Guclu-Geyik F; Ekici B
    Mol Biol Rep; 2021 Dec; 48(12):7719-7732. PubMed ID: 34689283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs as biomarkers for severe coronary artery disease.
    Zhang X; Cai H; Zhu M; Qian Y; Lin S; Li X
    Medicine (Baltimore); 2020 Apr; 99(17):e19971. PubMed ID: 32332683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population　- Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
    Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
    Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.
    Liu Y; Li Q; Hosen MR; Zietzer A; Flender A; Levermann P; Schmitz T; Frühwald D; Goody P; Nickenig G; Werner N; Jansen F
    Circ Res; 2019 Feb; 124(4):575-587. PubMed ID: 30582459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNA expression profiling and bioinformatics analysis of patients with coronary artery disease by RNA sequencing.
    Zhong Z; Zhong W; Zhang Q; Zhang Q; Yu Z; Wu H
    J Clin Lab Anal; 2020 Jan; 34(1):e23020. PubMed ID: 31489700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability.
    Singh S; de Ronde MWJ; Kok MGM; Beijk MA; De Winter RJ; van der Wal AC; Sondermeijer BM; Meijers JCM; Creemers EE; Pinto-Sietsma SJ
    Open Heart; 2020 Jun; 7(1):. PubMed ID: 32487772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa-miR-584-5p as a novel candidate biomarker in Turkish men with severe coronary artery disease.
    Coban N; Pirim D; Erkan AF; Dogan B; Ekici B
    Mol Biol Rep; 2020 Feb; 47(2):1361-1369. PubMed ID: 31863331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.
    Ozuynuk-Ertugrul AS; Ekici B; Erkan AF; Coban N
    Lab Med; 2024 May; 55(3):361-372. PubMed ID: 38048807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma miRNAs improve the prediction of coronary atherosclerosis in patients with rheumatoid arthritis.
    Ormseth MJ; Solus JF; Sheng Q; Chen SC; Ye F; Wu Q; Oeser AM; Allen R; Raggi P; Vickers KC; Stein CM
    Clin Rheumatol; 2021 Jun; 40(6):2211-2219. PubMed ID: 33389220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients.
    Mahjoob G; Ahmadi Y; Fatima Rajani H; Khanbabaei N; Abolhasani S
    J Clin Lab Anal; 2022 May; 36(5):e24380. PubMed ID: 35349731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
    DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
    Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of circulating pro-angiogenic microRNA expressions as biomarkers for rapid angiographic stenotic progression and restenosis risks in coronary artery disease patients underwent percutaneous coronary intervention.
    Dai R; Liu Y; Zhou Y; Xiong X; Zhou W; Li W; Zhou W; Chen M
    J Clin Lab Anal; 2020 Jan; 34(1):e23013. PubMed ID: 31495986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated miRNA-26a-5p induces the apoptosis of endothelial cells in coronary heart disease by inhibiting PI3K/AKT pathway.
    Jing R; Zhong QQ; Long TY; Pan W; Qian ZX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4940-4947. PubMed ID: 31210329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.
    Ormseth MJ; Solus JF; Vickers KC; Oeser AM; Raggi P; Stein CM
    J Rheumatol; 2015 Oct; 42(10):1746-1751. PubMed ID: 26233505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miR-128-3p and miR-195-5p as biomarkers of coronary artery disease in Indians: a pilot study.
    Choudhury RR; Gupta H; Bhushan S; Singh A; Roy A; Saini N
    Sci Rep; 2024 May; 14(1):11881. PubMed ID: 38789551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of circulating microRNA profiles in Brazilian women with polycystic ovary syndrome: A preliminary study.
    De Nardo Maffazioli G; Baracat EC; Soares JM; Carvalho KC; Maciel GAR
    PLoS One; 2022; 17(10):e0275031. PubMed ID: 36206272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes.
    Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.